2008
DOI: 10.1016/j.jocn.2007.04.010
|View full text |Cite
|
Sign up to set email alerts
|

Oxcarbazepine monotherapy in carbamazepine-unresponsive trigeminal neuralgia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
32
0
3

Year Published

2011
2011
2021
2021

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 70 publications
(38 citation statements)
references
References 27 publications
1
32
0
3
Order By: Relevance
“…[5] Various methods to synthesize these compounds have been reported in the literature. [6] Nevertheless, the development of new and efficient procedures for the selective synthesis of these seven-membered rings continues to represent an important and challenging goal.…”
mentioning
confidence: 99%
“…[5] Various methods to synthesize these compounds have been reported in the literature. [6] Nevertheless, the development of new and efficient procedures for the selective synthesis of these seven-membered rings continues to represent an important and challenging goal.…”
mentioning
confidence: 99%
“…OXC is recommended in patients who do not respond to CBZ. Carrazana found that the evidence supporting the use of OXC for trigeminal neuralgia is strong [9,10]. The use of OXC for other indications such as painful diabetic neuropathy, post-herpetic neuralgia, painful paroxysmal symptoms in multiple sclerosis, tremor, and migraine has already been investigated with a poor-moderate evidence level [5,[11][12][13][14].…”
Section: Discussionmentioning
confidence: 99%
“…С 1962 года и по настоящее время карбамазепин и его ана-логи (окскарбазепин, финлепсин, тегретол) являются препара-тами первой линии в лечении НТН [177,220,250,255,269,402,404,418,419,429,433]. За этот период накоплен большой опыт оценки эффективности и побочных явлений от длительного применения этого препарата.…”
Section: принципы лечения тригеминальной невралгииunclassified